Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethnicity and pharmacogenetics

M W Smith1, R P Mendoza

  • 1Department of Psychiatry, University of California, Los Angeles, USA.

The Mount Sinai Journal of Medicine, New York
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of the Positive Muon Anomalous Magnetic Moment to 0.46 ppm.

Physical review letters·2021
Same author

Incorporating hydrology into climate suitability models changes projections of malaria transmission in Africa.

Nature communications·2020
Same author

The effects of land use and topographic changes on sediment connectivity in mountain catchments.

The Science of the total environment·2019
Same author

Association of variants in genes related to the immune response and obesity with BPH in CLUE II.

Prostate cancer and prostatic diseases·2014
Same author

A simple, rapid, cost-effective and sensitive method for detection of Salmonella in environmental and pecan samples.

Journal of applied microbiology·2014
Same author

BNNT-mediated irreversible electroporation: its potential on cancer cells.

Technology in cancer research & treatment·2012
Same journal

Farewell message from Penny A. Asbell, MD, FACS, MBA, Editor-in-Chief of the Mount Sinai Journal of Medicine.

The Mount Sinai journal of medicine, New York·2012
Same journal

Minority undergraduate programs intended to increase participation in biomedical careers.

The Mount Sinai journal of medicine, New York·2012
Same journal

Future of electronic health records: implications for decision support.

The Mount Sinai journal of medicine, New York·2012
Same journal

AA amyloidosis: Mount Sinai experience, 1997-2012.

The Mount Sinai journal of medicine, New York·2012
Same journal

Amyloid neuropathies.

The Mount Sinai journal of medicine, New York·2012
Same journal

Should your family history of coronary heart disease scare you?

The Mount Sinai journal of medicine, New York·2012
See all related articles

Genetic factors significantly influence how different ethnic groups respond to psychotropic medications. Understanding these pharmacogenetic differences is crucial for personalized psychiatric treatment, considering both genetics and environment.

Area of Science:

  • Pharmacogenetics
  • Psychiatry
  • Genomics

Background:

  • Ethnic variations in drug response are well-documented.
  • Pharmacogenetics offers insights into the biological basis of these differences.
  • Genetic factors play a key role in the metabolism and binding of psychotropic drugs.

Purpose of the Study:

  • To explore the role of genetic factors in ethnic differences in psychotropic medication response.
  • To highlight the importance of pharmacogenetics in understanding differential patient outcomes.
  • To discuss the potential clinical applications of pharmacogenetic research in diverse populations.

Main Methods:

  • Review of emerging research methodologies in pharmacogenetics.
  • Analysis of genetic factors influencing drug metabolism and protein binding.

Related Experiment Videos

  • Consideration of environmental influences on psychopharmacological response.

    • Main Results:

    • Genetic variations are central to differential drug metabolism across ethnic groups.
    • Ethnic differences in genetic factors largely explain varied responses to psychotropic agents.
    • Environmental factors interact with genetic predispositions.

    Conclusions:

    • Pharmacogenetic insights are vital for understanding ethnic disparities in psychiatric medication efficacy.
    • Further research is needed to determine the clinical utility of pharmacogenetic testing.
    • Genotyping and phenotyping can inform psychopharmacotherapeutic decisions for diverse patient groups.